Source:http://linkedlifedata.com/resource/pubmed/id/12531225
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-1-17
|
pubmed:abstractText |
Several investigators have now established that chronic lymphocytic leukemia (CLL) is not a uniform disease entity, since approximately half of the cases of CLL have undergone immunoglobulin V region (IgV) hypermutation, whereas the other half display unmutated Ig genes. The median survival time of mutated CLL (M-CLL) cases has been shown to be approximately twice as long as that for unmutated CLL (UM-CLL), but no clear explanation for this difference is currently available. In this work, we have investigated a cohort of previously untreated CLL patients, to see whether the ex vivo sensitivities of leukemic cells of 16 UM-CLL patients differ from those of 8 M-CLL patients, using nine different drugs and two types of irradiation. Our results demonstrated very similar ex vivo sensitivities and tumor cell heterogeneity of sensitivity of UM-CLL and M-CLL cells when tested against chlorambucil, 2-chloro-2'-deoxyadenosine, cyclosporin A, cis-platinum(II)diammine-dichloride, doxorubicin hydrochloride, 2-fluoroadenine-9-beta-D-arabinofuranoside, prednisolone sodium succinate, verapamil, vincristine, gamma-irradiation, and UV-irradiation. This indicates that de novo chemo/radiosensitivity cannot explain the survival difference observed between UM-CLL and M-CLL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0145-2126
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
337-41
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12531225-Antineoplastic Agents,
pubmed-meshheading:12531225-Cell Survival,
pubmed-meshheading:12531225-Clone Cells,
pubmed-meshheading:12531225-Dose-Response Relationship, Drug,
pubmed-meshheading:12531225-Gamma Rays,
pubmed-meshheading:12531225-Humans,
pubmed-meshheading:12531225-Immunoglobulin Variable Region,
pubmed-meshheading:12531225-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:12531225-Prognosis,
pubmed-meshheading:12531225-Somatic Hypermutation, Immunoglobulin,
pubmed-meshheading:12531225-Ultraviolet Rays
|
pubmed:year |
2003
|
pubmed:articleTitle |
Ex vivo drug and irradiation sensitivities in hypermutated and unmutated forms of chronic lymphocytic leukemia cells.
|
pubmed:affiliation |
Department of Clinical Chemistry, HYKS (Jorvi Hospital), Espoo, Finland.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|